Scilex Holding (SCLXW) Asset Utilization Ratio (2022 - 2026)
Scilex Holding (SCLXW) recorded quarterly Asset Utilization Ratio of 0.1 in Q1 2026, up 8.87% quarter-over-quarter from 0.09 in Q4 2025, and down 82.55% on a YoY basis from 0.59 in Q1 2025.
Scilex Holding (SCLXW) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Scilex Holding's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.1 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 82.55% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (down 82.55% YoY), while the FY2025 annual figure was 0.13, down 77.29% from the prior year.
- Asset Utilization Ratio was 0.1 for Q1 2026 at Scilex Holding, up from 0.09 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.59 in Q1 2025 to a low of 0.09 in Q4 2025.
- Historically, Asset Utilization Ratio has averaged 0.43 across 5 years, with a median of 0.49 in 2023.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio rose 27.05% in 2023, then slumped 83.85% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.4 in 2022, then grew by 27.05% to 0.51 in 2023, then climbed by 13.84% to 0.59 in 2024, then sank by 83.85% to 0.09 in 2025, then climbed by 8.87% to 0.1 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.1 (Q1 2026), 0.09 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 0.53 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.63 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.48 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.46 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.12 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.55 |
| 10 | Scilex Holding | - | - | 4.15 Mn | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.54 |
| Mar 31, 2025 | 0.59 |
| Dec 31, 2024 | 0.59 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | 0.52 |
| Mar 31, 2024 | 0.49 |
| Dec 31, 2023 | 0.51 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.40 |